Related references
Note: Only part of the references are listed.Comprehensive analysis of Methylenetetrahydrofolate reductase C677T in younger acute lymphoblastic leukemia patients: A single-center experience
Rim Frikha et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Associations between the C677T and A1298C polymorphisms of MTHFR and the toxicity of methotrexate in childhood malignancies: a meta-analysis
C. Zhu et al.
PHARMACOGENOMICS JOURNAL (2018)
Pharmacogenomics and variations in the risk of toxicity during the consolidation/maintenance phases of the treatment of pediatric B-cell leukemia patients from an admixed population in the Brazilian Amazon
Darlen Cardoso de Carvalho et al.
LEUKEMIA RESEARCH (2018)
Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia
Lobna Ben Mahmoud et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment
Angela Gutierrez-Camino et al.
PHARMACOGENOMICS (2018)
MTHFR variant is associated with high-dose methotrexate-induced toxicity in the Chinese osteosarcoma patients
Xu Leilei et al.
JOURNAL OF BONE ONCOLOGY (2018)
Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate
Yun Jung Choi et al.
HEMATOLOGICAL ONCOLOGY (2017)
The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia
Angela Gutierrez-Camino et al.
PHARMACOGENETICS AND GENOMICS (2017)
The role of the MTHFR C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients
Loes Lambrecht et al.
PHARMACOGENOMICS (2017)
Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia
Burcu Yazicioglu et al.
TURKISH JOURNAL OF HEMATOLOGY (2017)
More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate
Lu Xie et al.
Oncotarget (2017)
Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
Shu-Guang Liu et al.
ONCOTARGET (2017)
Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
Barbara Faganel Kotnik et al.
RADIOLOGY AND ONCOLOGY (2017)
Mexican Childhood Acute Lymphoblastic Leukemia: A Pilot Study of the MDR1 and MTHFR Gene Polymorphisms and Their Associations with Clinical Outcomes
Arturo Ramirez-Pacheco et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2016)
Seventeen years of statin pharmacogenetics: a systematic review
Maarten Leusink et al.
PHARMACOGENOMICS (2016)
MTHFR gene polymorphisms and methotrexate toxicity in adult patients with hematological malignancies: a meta-analysis
Ming Zhao et al.
PHARMACOGENOMICS (2016)
Effect of folate status and methylenetetrahydrofolate reductase genotypes on the complications and outcome of high dose methotrexate chemotherapy in north Indian children with acute lymphoblastic leukemia
Nirmalya Roy Moulik et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2016)
Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma
Jeong A. Park et al.
BLOOD RESEARCH (2016)
Inherited genetic variation in childhood acute lymphoblastic leukemia
Takaya Moriyama et al.
BLOOD (2015)
Pharmacogenomics in the clinic
Mary V. Relling et al.
NATURE (2015)
Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate
S. Jabeen et al.
PHARMACOGENOMICS JOURNAL (2015)
Role of folate status and methylenetetrahydrofolate reductase genotype on the toxicity and outcome of induction chemotherapy in children with acute lymphoblastic leukemia
Nirmalya Roy Moulik et al.
LEUKEMIA & LYMPHOMA (2015)
Pharmacogenetic studies in children with acute lymphoblastic leukemia in Argentina
Hilda Veronica Araoz et al.
LEUKEMIA & LYMPHOMA (2015)
Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia
M. A. H. den Hoed et al.
PHARMACOGENOMICS JOURNAL (2015)
Genetic model selection for a case-control study and a meta-analysis
Nobuyuki Horita et al.
META GENE (2015)
MTHFR C677T polymorphism: association with lymphoid neoplasm and effect on methotrexate therapy
Mona W. Ayad et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Association of-24CT, 1249GA, and 3972CT ABCC2 Gene Polymorphisms with Methotrexate Serum Levels and Toxic Side Effects in Children with Acute Lymphoblastic Leukemia
Mohamad Jafar Sharifi et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2014)
Pharmacogenetics of MicroRNAs and MicroRNAs Biogenesis Machinery in Pediatric Acute Lymphoblastic Leukemia
Elixabet Lopez-Lopez et al.
PLOS ONE (2014)
Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies
Sujatha Suthandiram et al.
PHARMACOGENOMICS (2014)
The influence of folate pathway polymorphisms on high-dose methotrexaterelated toxicity and survival in children with non-Hodgkin malignant lymphoma
Nina Erculj et al.
RADIOLOGY AND ONCOLOGY (2014)
Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia
Susanne Radtke et al.
BLOOD (2013)
C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia
Deena Samir Eissa et al.
BLOOD COAGULATION & FIBRINOLYSIS (2013)
FPGS rs1544105 polymorphism is associated with treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia
Shu-Guang Liu et al.
CANCER CELL INTERNATIONAL (2013)
Germline Genetic Polymorphisms May Influence Chemotherapy Response and Disease Outcome in Osteosarcoma
Rachael E. Windsor et al.
CANCER (2012)
Methotrexate: a detailed review on drug delivery and clinical aspects
Zulfequar Ahamad Khan et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity
Gabriele Stocco et al.
HUMAN MOLECULAR GENETICS (2012)
High Dose Methotrexate Treatment in Childhood ALL: Pilot Study on the Impact of the MTHFR 677C>T and 1298A>C Polymorphisms on MTX-related Toxicity
R. Haase et al.
KLINISCHE PADIATRIE (2012)
Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia
Nina Erculj et al.
LEUKEMIA & LYMPHOMA (2012)
Genetic Polymorphism of γ-Glutamyl Hydrolase in Chinese Acute Leukemia Children and Identification of a Novel Double Nonsynonymous Mutation
Xiaowen Chen et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2012)
Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta-analysis
Kalliopi P. Spyridopoulou et al.
PHARMACOGENETICS AND GENOMICS (2012)
Polymorphisms in the methotrexate transport pathway
Elixabet Lopez-Lopez et al.
Pharmacogenetics and Genomics (2012)
Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia
J. Salazar et al.
PHARMACOGENOMICS JOURNAL (2012)
Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma
Barbara Faganel Kotnik et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
The Role of the Methylenetetrahydrofolate Reductase 677 and 1298 Polymorphisms in Cretan Children with Acute Lymphoblastic Leukemia
Nikolaos V. Karathanasis et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2011)
Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population
Shu-Guang Liu et al.
LEUKEMIA & LYMPHOMA (2011)
Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia
Azza A. G. Tantawy et al.
BLOOD COAGULATION & FIBRINOLYSIS (2010)
Practical Issues in Building Risk-Predicting Models for Complex Diseases
Jia Kang et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2010)
Relationship of the reduced folate carrier gene polymorphism G80A to methotrexate plasma concentration, toxicity, and disease outcome in childhood acute lymphoblastic leukemia
Barbara Faganel Kotnik et al.
LEUKEMIA & LYMPHOMA (2010)
SLC19A1 pharmacogenomics summary
Sook Wah Yee et al.
PHARMACOGENETICS AND GENOMICS (2010)
Advances in individual prediction of methotrexate toxicity: a review
Kjeld Schmiegelow
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival
Alessia Ongaro et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement
Julian Little et al.
HUMAN GENETICS (2009)
Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects
Lisa R. Trevin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia
L. Huang et al.
LEUKEMIA (2008)
Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia
Samart Pakakasama et al.
ANNALS OF HEMATOLOGY (2007)
Ancestry and phannacogenetics of antileukernic drug toxicity
Shinji Kishi et al.
BLOOD (2007)
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival
Donato Gemmati et al.
HAEMATOLOGICA (2007)
The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida
Ivon J. M. Van der Linden et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
MTHFR 677 (C→T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL:: results from 484 patients of multicenter trial NHL-BFM 95
Kathrin Seidemann et al.
ANNALS OF HEMATOLOGY (2006)
Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma
N Shimasaki et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2006)
Perspectives on cancer therapy-induced mucosal injury - Pathogenesis, measurement, epidemiology, and consequences for patients
ST Sonis et al.
CANCER (2004)
Share Paper
